117 related articles for article (PubMed ID: 35775338)
1. Morbidity following transperineal prostate biopsy: Our experience in 8.500 men.
Pepe P; Pennisi M
Arch Ital Urol Androl; 2022 Jun; 94(2):155-159. PubMed ID: 35775338
[TBL] [Abstract][Full Text] [Related]
2. Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores.
Pepe P; Aragona F
Urology; 2013 Jun; 81(6):1142-6. PubMed ID: 23726443
[TBL] [Abstract][Full Text] [Related]
3. Transperineal Versus Transrectal MRI/TRUS Fusion Targeted Biopsy: Detection Rate of Clinically Significant Prostate Cancer.
Pepe P; Garufi A; Priolo G; Pennisi M
Clin Genitourin Cancer; 2017 Feb; 15(1):e33-e36. PubMed ID: 27530436
[TBL] [Abstract][Full Text] [Related]
4. How Many Cores Should be Obtained During Saturation Biopsy in the Era of Multiparametric Magnetic Resonance? Experience in 875 Patients Submitted to Repeat Prostate Biopsy.
Pepe P; Pennisi M; Fraggetta F
Urology; 2020 Mar; 137():133-137. PubMed ID: 31758981
[TBL] [Abstract][Full Text] [Related]
5. Is it Time to Perform Only Magnetic Resonance Imaging Targeted Cores? Our Experience with 1,032 Men Who Underwent Prostate Biopsy.
Pepe P; Garufi A; Priolo GD; Galia A; Fraggetta F; Pennisi M
J Urol; 2018 Oct; 200(4):774-778. PubMed ID: 29679618
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of transperineal template saturation prostate biopsy versus magnetic resonance imaging targeted biopsy with magnetic resonance imaging-ultrasound fusion guidance.
Radtke JP; Kuru TH; Boxler S; Alt CD; Popeneciu IV; Huettenbrink C; Klein T; Steinemann S; Bergstraesser C; Roethke M; Roth W; Schlemmer HP; Hohenfellner M; Hadaschik BA
J Urol; 2015 Jan; 193(1):87-94. PubMed ID: 25079939
[TBL] [Abstract][Full Text] [Related]
7. How Many Targeted Biopsy Cores are Needed for Clinically Significant Prostate Cancer Detection during Transperineal Magnetic Resonance Imaging Ultrasound Fusion Biopsy?
Song G; Ruan M; Wang H; Fan Y; He Q; Lin Z; Li X; Li P; Wang X; He Z; Zhou L
J Urol; 2020 Dec; 204(6):1202-1208. PubMed ID: 32716686
[TBL] [Abstract][Full Text] [Related]
8. Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China.
Zhang Q; Wang W; Zhang B; Shi J; Fu Y; Li D; Guo S; Zhang S; Huang H; Jiang X; Zhou W; Guo H
Int Urol Nephrol; 2017 Mar; 49(3):439-448. PubMed ID: 28005230
[TBL] [Abstract][Full Text] [Related]
9. Optimizing the Number of Cores Targeted During Prostate Magnetic Resonance Imaging Fusion Target Biopsy.
Kenigsberg AP; Renson A; Rosenkrantz AB; Huang R; Wysock JS; Taneja SS; Bjurlin MA
Eur Urol Oncol; 2018 Oct; 1(5):418-425. PubMed ID: 31158081
[TBL] [Abstract][Full Text] [Related]
10. Detection rate for significant cancer at confirmatory biopsy in men enrolled in Active Surveillance protocol: 20 cores vs 30 cores vs MRI/TRUS fusion prostate biopsy.
Pepe P; Cimino S; Garufi A; Priolo G; Russo GI; Giardina R; Reale G; Barbera M; Panella P; Pennisi M; Morgia G
Arch Ital Urol Androl; 2016 Dec; 88(4):300-303. PubMed ID: 28073197
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging and Fusion Guided Targeted Biopsy Evaluated by Transperineal Template Saturation Prostate Biopsy for the Detection and Characterization of Prostate Cancer.
Mortezavi A; Märzendorfer O; Donati OF; Rizzi G; Rupp NJ; Wettstein MS; Gross O; Sulser T; Hermanns T; Eberli D
J Urol; 2018 Aug; 200(2):309-318. PubMed ID: 29474846
[TBL] [Abstract][Full Text] [Related]
12. Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer.
Borkowetz A; Platzek I; Toma M; Laniado M; Baretton G; Froehner M; Koch R; Wirth M; Zastrow S
BJU Int; 2015 Dec; 116(6):873-9. PubMed ID: 25523210
[TBL] [Abstract][Full Text] [Related]
13. Robot-assisted Magnetic Resonance Imaging-ultrasound Fusion Transperineal Targeted Biopsy.
Lee AY; Chen K; Law YM; Ho HS; Cheng CW; Yuen JS; Tay KJ
Urology; 2021 Sep; 155():46. PubMed ID: 34186128
[TBL] [Abstract][Full Text] [Related]
14. Optimising the number of cores for magnetic resonance imaging-guided targeted and systematic transperineal prostate biopsy.
Hansen NL; Barrett T; Lloyd T; Warren A; Samel C; Bratt O; Kastner C
BJU Int; 2020 Feb; 125(2):260-269. PubMed ID: 31306539
[TBL] [Abstract][Full Text] [Related]
15. A Single Center Evaluation of the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging against Transperineal Prostate Mapping Biopsy: An Analysis of Men with Benign Histology and Insignificant Cancer following Transrectal Ultrasound Biopsy.
Pal RP; Ahmad R; Trecartan S; Voss J; Ahmed S; Bazo A; Lloyd J; Walton TJ
J Urol; 2018 Aug; 200(2):302-308. PubMed ID: 29477717
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 4: Transperineal Magnetic Resonance-Ultrasound Fusion Guided Biopsy Using Local Anesthesia.
Immerzeel J; Israël B; Bomers J; Schoots IG; van Basten JP; Kurth KH; de Reijke T; Sedelaar M; Debruyne F; Barentsz J
Eur Urol; 2022 Jan; 81(1):110-117. PubMed ID: 34799197
[TBL] [Abstract][Full Text] [Related]
17. Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy.
Vėželis A; Platkevičius G; Kinčius M; Gumbys L; Naruševičiūtė I; Briedienė R; Petroška D; Ulys A; Jankevičius F
Medicina (Kaunas); 2021 Jan; 57(1):. PubMed ID: 33435132
[No Abstract] [Full Text] [Related]
18. Outcomes of freehand transperineal prostate biopsy with omission of antibiotic prophylaxis.
Setia SA; Smith J; Cendo D; Yoder J; Gorin MA; Allaway MJ; Vourganti S
BJU Int; 2022 Jul; 130(1):54-61. PubMed ID: 34491606
[TBL] [Abstract][Full Text] [Related]
19. Utility of early transperineal template-guided prostate biopsy for risk stratification in men undergoing active surveillance for prostate cancer.
Voss J; Pal R; Ahmed S; Hannah M; Jaulim A; Walton T
BJU Int; 2018 Jun; 121(6):863-870. PubMed ID: 29239082
[TBL] [Abstract][Full Text] [Related]
20. Not All Multiparametric Magnetic Resonance Imaging-targeted Biopsies Are Equal: The Impact of the Type of Approach and Operator Expertise on the Detection of Clinically Significant Prostate Cancer.
Stabile A; Dell'Oglio P; Gandaglia G; Fossati N; Brembilla G; Cristel G; Dehò F; Scattoni V; Maga T; Losa A; Gaboardi F; Cardone G; Esposito A; De Cobelli F; Del Maschio A; Montorsi F; Briganti A
Eur Urol Oncol; 2018 Jun; 1(2):120-128. PubMed ID: 31100235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
